Filter News
Area of Research
- (-) Isotopes (8)
- Advanced Manufacturing (4)
- Biological Systems (2)
- Biology and Environment (135)
- Biology and Soft Matter (1)
- Clean Energy (159)
- Climate and Environmental Systems (5)
- Computational Biology (2)
- Computational Engineering (2)
- Computer Science (4)
- Electricity and Smart Grid (1)
- Energy Sciences (1)
- Functional Materials for Energy (2)
- Fusion and Fission (8)
- Fusion Energy (1)
- Materials (93)
- Materials for Computing (7)
- Mathematics (1)
- National Security (31)
- Neutron Science (39)
- Nuclear Science and Technology (7)
- Quantum information Science (3)
- Supercomputing (83)
Media Contacts
After retiring from Y-12, Scott Abston joined the Isotope Science and Engineering Directorate to support isotope production and work with his former manager. He now leads a team maintaining critical equipment for medical and space applications. Abston finds fulfillment in mentoring his team and is pleased with his decision to continue working.
Raina Setzer knows the work she does matters. That’s because she’s already seen it from the other side. Setzer, a radiochemical processing technician in Oak Ridge National Laboratory’s Isotope Processing and Manufacturing Division, joined the lab in June 2023.
Three scientists from the Department of Energy’s Oak Ridge National Laboratory have been elected fellows of the American Association for the Advancement of Science, or AAAS.
Oak Ridge National Laboratory scientists recently demonstrated a low-temperature, safe route to purifying molten chloride salts that minimizes their ability to corrode metals. This method could make the salts useful for storing energy generated from the sun’s heat.
Researchers at ORNL explored radium’s chemistry to advance cancer treatments using ionizing radiation.
As a medical isotope, thorium-228 has a lot of potential — and Oak Ridge National Laboratory produces a lot.
A rare isotope in high demand for treating cancer is now more available to pharmaceutical companies developing and testing new drugs.
When Sandra Davern looks to the future, she sees individualized isotopes sent into the body with a specific target: cancer cells.